93 results
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
to injury. NAFLD may evolve into NASH when the fatty liver begins to progress through stages of cell injury, inflammation, fibrosis … injury to the liver leads to many genetic mutations that eventually lead to transformation of cells and formation of tumors. The noxious tissue
8-K
EX-99.1
s0zxvd97hoxy odwknon
24 Jul 23
Regulation FD Disclosure
4:04pm
424B5
hb5vb32owru15
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.2
sb5se
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
eim 69jerv
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
p1e8e
17 Oct 22
Regulation FD Disclosure
5:13pm
8-K
EX-99.1
qmabh0y
27 May 22
Regulation FD Disclosure
8:44am
8-K
EX-99.1
tieaw4vnemi6 fxy4b
10 Jan 22
Regulation FD Disclosure
6:02am
8-K
EX-99.2
t450nquy88gic zz4hho
10 Nov 21
Hepion Pharmaceuticals Announces Poster Details for the Upcoming AASLD The Liver Meeting® 2021
9:41am